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The effect of α-methyl-5-hydroxytryptamine maleate, an agonist of 5-HT2B serotonin recep-
tors, on the pumping function of the heart was examined in rats with forced motor behavior. At 
rest, swim-trained rats demonstrated lower HR and greater stroke volume and cardiac output 
than untrained rats. The agonist decreased HR, stroke volume, and cardiac output in 21- and 
70-day-old swim-trained rats, but not in 100- and 200-day-old rats.
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During postnatal ontogeny, serotonin exerts both 
stimulating and inhibitory age-dependent effects on 
the pumping function of rat heart and mechanisms 
of its regulation [1,4,6,7]. The responses of cardiac 
serotonin receptors were examined on 70-day-old rats 
subjected to muscle training [6]. To study the mecha-
nisms of pumping function regulation, the regimens 
of swimming training were elaborated for rats at the 
Department of Physical Exercise Physiology, Kazan 
Federal University [5,8,10].
Here we studied the role of 5-HT2B serotonin re-
ceptors in the regulation of pumping function of the 
heart during the growth and development of the rats 
with forced motor activity.
MATERIALS AND METHODS
Experiments were carried out on the rats aging 21, 
70, 100, and 200 days. In each age group, the experi-
mental rats were subjected to forced motor activity in 
contrast to the control animals with unrestricted motor 
behavior.
The experimental rats were adapted to swimming 
with stepwise increasing load. On training day 1, the 
duration of exercise was 5 min and then the dura-
tion of single training session increased by 5 min in 
every other day, so to the end of training week 2, it 
maximized to 30 min. The total training duration in-
creased every day by 10 min, so to the end of training 
week 4, it attained 90 min. During training week 5, 
the experimental rats were subjected to swimming 
for 90 min, including a 30-min loaded forced swim-
ming test with a 3% body weight load. During the 
loaded forced swimming test, a metal load was fi xed 
to the body with a fi ne rubber band in such a way that 
it did not impede respiration. The same regimen was 
employed on training week 6 except for increasing the 
load to 5% body weight. During training weeks 7 to 26, 
the duration of swimming test with a 5% body weight 
load was 60 min. The experimental rats were subjected 
to swimming training sessions for 6 days in a week.
The control rats were maintained under the condi-
tions of free motor behavior. They were kept by 5-6 
animals per cage and demonstrated spontaneous motor 
behavior that was neither restricted, nor stimulated.
To study HR, stroke volume (SV), and cardiac 
output (CO), the rats were narcotized with urethane 
(800 mg/kg body weight) and the differential and inte-
gral rheograms were recorded under natural respiration 
[9] using a modifi ed method [3].
In 10-15 min after injection of urethane, α-methyl-
5-hydroxytryptamine maleate (Tocris), an agonist of 
5-HT2B serotonin receptors, was injected three times 
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into the femoral vein via a catheter in increasing doses 
of 1, 10, and 30 mg/kg, the interval between injections 
was 10 min [11]; the maximum changes in HR, SV, 
and CO were recorded after each dose.
The data were analyzed statistically using Chart, 
Claris Works, and Statistica 6.0 softwares. Signifi -
cance was assessed by Student’s t test at p≤0.05.
RESULTS
At rest, HR in 70-day-old swim-trained animals was 
lower by 118.1 bpm than that in 21-day-old ones 
(p≤0.05) and by 9 bpm higher than in 70-day-old con-
trols. Further decrease of HR at rest was observed in 
100-day-old rats in comparison with 70-day-old ani-
mals. The difference in HR of control and experimen-
tal rats was used as the indicator of effi cacy of muscle 
training. In 70-day-old rats, this difference was 28.8 
bpm (p≤0.05). In 200-day-old experimental rats, HR 
at rest (290.0±4.1 bpm) was lower by 19.2 bpm than 
that in age-matched controls (p≤0.05).
In 21-day-old rats, SV at rest was 0.074 ml. In 
70-day-old experimental animals, it increased to 0.225 
ml (p≤0.05). At this age, SV in control rats was low-
er by 0.031 ml than that in the age-matched experi-
mental animals (p≤0.05). In 100-day-old experimen-
tal rats, SV was higher by 0.039 ml than in control 
animals. In 200-day-old experimental rats, SV was 
0.362±0.006 ml and surpassed the control value by 
0.032 ml (p≤0.05). Thus, SV increased with age in 
all rats, but the increments were more pronounced in 
experimental (swim-trained) rats.
In 21-day-old rats at rest, CO was 36.16±1.80 
ml/min. In 70-day-old experimental animals, it in-
creased by 73.49 (p≤0.05). In 100-day-old experimen-
tal rats, CO somewhat decreased, which evidently re-
fl ected the drop in HR at rest. In 100- and 200-day-old 
experimental rats, CO was similar.
In 21-day-old rats, the fi rst dose of the agonist 
decreased HR by 26 bpm on postinjection minute 10 
(p≤0.05). The second dose of this agent induced fur-
ther drop in HR by 22 bpm on postinjection minute 
10, so the total drop was 48 bpm (p≤0.05). Thus, two 
injected doses of the agonist pronouncedly decreased 
HR in 21-day-old rats.
In 70-day-old experimental rats, the fi rst dose of 
the agonist decreased HR by 37.2 bpm on postinjection 
minute 10 (p≤0.05). In comparison with the second 
dose, the third one produced no signifi cant changes in 
HR. In 100-day-old experimental rats, the fi rst dose 
of the agonist produced somewhat lower decrement 
in HR than that in 70-day-old rats. In 100-day-old 
control rats, the agonist decreased HR by 13.1 bpm 
(p≤0.05). In 200-day-old rats, all doses of the agonist 
produced no signifi cant changes in HR. Thus, the most 
pronounced changes in HR induced by the agonist of 
5-HT2B serotonin receptors were observed in 21-day-
old rats, while in 70-day-old rats the corresponding 
HR changes were slightly lower. In contrast, the ago-
nist produced no signifi cant changes in HR of 100- and 
200-day-old rats.
In 21-day-old control rats, the fi rst dose of the ag-
onist decreased SV. After the second dose, the decre-
ment was more pronounced (in comparison with initial 
values), being 0.032 ml (p≤0.05). In 70-day-old ex-
perimental rats, the second dose of agonist decreased 
SV by 0.029 ml on postinjection minute 10 (p≤0.05). 
In 70-day-old control rats, the third dose of agonist 
decreased SV by 0.027 ml (p≤0.05). No changes in 
SV were observed in 100- and 200-day-old rats after 
three injections of the agonist.
In 21-day-old control rats, the fi rst dose of the 
agonist decreased CO to postinjection minute 6 
(p≤0.05). A more pronounced drop of CO (by 19.75 
ml/min, p≤0.05) was observed after the third injec-
tion. In 70-day-old experimental rats, the second dose 
of the agonist decreased CO by 22.15 ml/min (p≤0.05). 
In age-matched control rats, CO dropped by 18.1 
ml/min (p≤0.05). In 100-day-old experimental rats, the 
third dose of the agonist decreased CO by 11.4 ml/min 
(p≤0.05). In age-matched control rats, the third dose of 
the agonist insignifi cantly decreased CO by 6.7 ml/min 
(p>0.05). In 200-day-old control and experimental 
rats, the agonist-induced drop in CO was no more than 
3 ml/min (p>0.05). Thus, only 21- and 70-day-old rats 
demonstrated signifi cant CO decrement after injection 
of the agonist of 5-HT2B serotonin receptors.
The observed effects of forced motor activ-
ity on HR, SV, and CO refi ned the peculiarities of 
cardiac pumping function modulation during regu-
lar muscle training [1,2,6]. Therefore, α-methyl-5-
hydroxytryptamine maleate, an agonist of 5-HT2B 
serotonin receptors, decreased the indices of cardiac 
pumping function. The most pronounced drops in 
HR, SV, and CO were observed in 21-day-old rats. In 
70-day-old rats, the decrements of these parameters 
were less pronounced, but still signifi cant. However, 
in 100- and 200-day-old rats, the examined serotonin 
agonist did not signifi cantly change HR, SV, and CO. 
Thus, α-methyl-5-hydroxytryptamine maleate, an ago-
nist of 5-HT2B serotonin receptors, reduced the indices 
of cardiac pumping function only at the early stages 
of ontogeny (in 21- and 71-day-old rats).
REFERENCES
 1. R. A. Abzalov, N. I. Abzalov, A. M. Valeev, et al., Vet. Vrach, 
No. 3, 46-49 (2012).
 2. R. A. Abzalov and R. R. Abzalov, Teor. Prakt. Fiz. Kult., No. 
3, 14-16 (1998).
R. A. Abzalov, R. R. Abzalov, et al.
304
 3. R. A. Abzalov and F. G. Sitdikov, The Developing Heart and 
Motion Regimen [in Russian], Kazan (1998).
 4. V. F. Akhmetzyanov, I. A. Latfullin, and R. R. Nigmatullina, 
Kazan. Med. Zh., No. 2, 110-121 (2006).
 5. A. M. Valeev, Teor. Prakt. Fiz. Kult., No. 10, 20-22 (2009).
 6. A. M. Valeev, N. I. Abzalov, R. A. Abzalov, et al., Bull. Exp. 
Biol. Med., 153, No. 3, 315-318 (2012).
 7. V. V. Kirillova and R. R. Nigmatiullina, Ross. Fiziol. Zh., 93, 
No. 10, 1132-1142 (2007).
 8. A. S. Nikitin, R. A. Abzalov, N. I. Abzalov, and E. Z. Vafi na, 
Ross. Fiziol. Zh., 99, No. 8, 937-944 (2013).
 9. W. G. Kubicek, J. Kottke, M. U. Ramos, et al., Biomed. Eng., 
9, No. 9, 410-416 (1974).
10. R. R. Nigmatullina, R. A. Abzalov, I. G. Khuramshin, and 
N. I. Abzalov Ross. Fiziol. Zh., 86, No. 12, 1580-1586 (2000).
11. H. Obata, S. Saito, M. Sasaki, et al., Pain, 90, Nos. 1-2, 173-
179 (2001).
Bulletin of Experimental Biology and Medicine, Vol. 159, No. 3, July, 2015 PHYSIOLOGY
